One-hour, microfluidic SARS-CoV-2 antibody immunoassay

In this white paper, Gyros Protein Technologies demonstrates how high-quality reagents from Sino Biological can be used in a high-performance, one-hour microfluidic, nanoliterscale immunoassay using Gyrolab^® platform for the qualitative detection of total antibodies generated against the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 in human serum samples.

Download it below to explore details of the miniaturized, microfluidic SARS-CoV-2 antibody immunoassay development and learn more about the future directions for Gyrolab assay development to detect SARS-CoV-2 antibodies.